Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 112
Filter
1.
Int J Mol Sci ; 22(18)2021 Sep 18.
Article in English | MEDLINE | ID: mdl-34576250

ABSTRACT

Anderson-Fabry disease (AFD) is a rare disease with an incidenceof approximately 1:117,000 male births. Lysosomal accumulation of globotriaosylceramide (Gb3) is the element characterizing Fabry disease due to a hereditary deficiency α-galactosidase A (GLA) enzyme. The accumulation of Gb3 causes lysosomal dysfunction that compromises cell signaling pathways. Deposition of sphingolipids occurs in the autonomic nervous system, dorsal root ganglia, kidney epithelial cells, vascular system cells, and myocardial cells, resulting in organ failure. This manuscript will review the molecular pathogenetic pathways involved in Anderson-Fabry disease and in its organ damage. Some studies reported that inhibition of mitochondrial function and energy metabolism plays a significant role in AFD cardiomyopathy and in kidney disease of AFD patients. Furthermore, mitochondrial dysfunction has been reported as linked to the dysregulation of the autophagy-lysosomal pathway which inhibits the mechanistic target of rapamycin kinase (mTOR) mediated control of mitochondrial metabolism in AFD cells. Cerebrovascular complications due to AFD are caused by cerebral micro vessel stenosis. These are caused by wall thickening resulting from the intramural accumulation of glycolipids, luminal occlusion or thrombosis. Other pathogenetic mechanisms involved in organ damage linked to Gb3 accumulation are endocytosis and lysosomal degradation of endothelial calcium-activated intermediate-conductance potassium ion channel 3.1 (KCa3.1) via a clathrin-dependent process. This process represents a crucial event in endothelial dysfunction. Several studies have identified the deacylated form of Gb3, globotriaosylsphingosine (Lyso-Gb3), as the main catabolite that increases in plasma and urine in patients with AFD. The mean concentrations of Gb3 in all organs and plasma of Galactosidase A knockout mice were significantly higher than those of wild-type mice. The distributions of Gb3 isoforms vary from organ to organ. Various Gb3 isoforms were observed mainly in the kidneys, and kidney-specific Gb3 isoforms were hydroxylated. Furthermore, the action of Gb3 on the KCa3.1 channel suggests a possible contribution of this interaction to the Fabry disease process, as this channel is expressed in various cells, including endothelial cells, fibroblasts, smooth muscle cells in proliferation, microglia, and lymphocytes. These molecular pathways could be considered a potential therapeutic target to correct the enzyme in addition to the traditional enzyme replacement therapies (ERT) or drug chaperone therapy.


Subject(s)
Endothelial Cells/metabolism , Fabry Disease/drug therapy , Fabry Disease/metabolism , MicroRNAs/metabolism , Animals , Autophagy , Cerebrovascular Circulation , Constriction, Pathologic , Enzyme Replacement Therapy , Fabry Disease/physiopathology , Globosides/chemistry , Glycolipids/metabolism , Humans , Lysosomes/chemistry , Mice , Microcirculation , Mitochondria/metabolism , Protein Isoforms , Signal Transduction , Sphingolipids/metabolism , TOR Serine-Threonine Kinases/metabolism , Trihexosylceramides/chemistry , Trihexosylceramides/metabolism , alpha-Galactosidase/metabolism
2.
J Chem Theory Comput ; 17(4): 2488-2501, 2021 Apr 13.
Article in English | MEDLINE | ID: mdl-33794087

ABSTRACT

The recognition of carbohydrate receptors on host cell membranes by pathogenic lectins is a crucial step in the microbial invasion. Two bacterial lectins, the B-subunit of Shiga toxin from Shigella dysenteria (StxB) and lectin I from Pseudomonas aeruginosa (LecA), are specific to the same galactolipid-globotriaosylceramide (Gb3). In this study we present a coarse-grained (cg) model of Gb3, which we further apply to unravel the molecular details of glycolipid binding by two lectins on the surface of a DOPC/cholesterol/Gb3 bilayer. In cg molecular dynamics simulations with time scales of dozens of microseconds, Gb3 was randomly distributed. The binding of both StxB or LecA is accompanied by Gb3 clustering in a cholesterol environment and with exclusion of DOPC in protein vicinity. StxB being bound by all 15 binding sites induced membrane bending, while LecA interacted with two out of four binding sites for most of the time causing a smaller inward curvature of the model membrane. Stable interactions occurred preferably when LecA was normal to the membrane surface. Furthermore, all-atom simulations revealed that LecA bound Gb3's headgroup at only one out of two possible conformations of the carbohydrate moiety observed at protein-free conditions. The results shed light on the mechanism of interactions between two lectins and Gb3 on the membrane surface and offer a coarse-grained model to study more complex systems at large spatiotemporal scales.


Subject(s)
Lectins/chemistry , Molecular Dynamics Simulation , Trihexosylceramides/chemistry , Binding Sites , Pseudomonas aeruginosa/chemistry
3.
Biochem Biophys Res Commun ; 557: 247-253, 2021 06 11.
Article in English | MEDLINE | ID: mdl-33894410

ABSTRACT

Accumulation of amyloid-ß peptide (Aß) in neuronal cells and in the extracellular regions in the brain is a major cause of Alzheimer's disease (AD); therefore, inhibition of Aß accumulation offers a promising approach for therapeutic strategies against AD. Aß is produced by sequential proteolysis of amyloid precursor protein (APP) in late/recycling endosomes after endocytosis of APP located in the plasma membrane. Aß is then released from cells in a free form or in an exosome-bound form. Shiga toxin (Stx) is a major virulence factor of enterohemorrhagic Escherichia coli. Recently, we found that one of the Stx subtypes, Stx2a, has a unique intracellular transport route after endocytosis through its receptor-binding B-subunit. A part of Stx2a can be transported to late/recycling endosomes and then degraded in a lysosomal acidic compartment, although in general Stx is transported to the Golgi and then to the endoplasmic reticulum in a retrograde manner. In this study, we found that treatment of APP-expressing cells with a mutant Stx2a (mStx2a), lacking cytotoxic activity because of mutations in the catalytic A-subunit, stimulated the transport of APP to the acidic compartment, which led to degradation of APP and a reduction in the amount of Aß. mStx2a-treatment also inhibited the extracellular release of Aß. Therefore, mStx2a may provide a new strategy to inhibit the production of Aß by modulating the intracellular transport of APP.


Subject(s)
Amyloid beta-Peptides/metabolism , Amyloid beta-Protein Precursor/metabolism , Cell Membrane/drug effects , Endosomes/metabolism , Lysosomes/metabolism , Protein Transport/drug effects , Shiga Toxin 2/pharmacology , Animals , CHO Cells , Catalytic Domain/genetics , Cell Membrane/metabolism , Cell Survival/drug effects , Cricetulus , Globosides/chemistry , Humans , Mutation , Phosphatidylcholines/chemistry , Recombinant Proteins , Shiga Toxin 2/chemistry , Shiga Toxin 2/genetics , Trihexosylceramides/chemistry
4.
J Chromatogr A ; 1638: 461895, 2021 Feb 08.
Article in English | MEDLINE | ID: mdl-33477028

ABSTRACT

Identification of 19 molecular species of globotriaosylceramides (Gb3) in extracts from a Fabry's plasma patient and a healthy control was performed by High-Performance Thin-Layer Chromatography (HPTLC)-densitometry and online coupling to Mass Spectrometry (MS). Separation was carried out on LiChrospher plates using Automated Multiple Development (AMD). Densitometry was performed on twin plates by combining detection in the visible at 550 nm, through previous on-plate orcinol derivatization, and by Ultraviolet 190 nm, using a non-impregnated plate. The latter was directly coupled to an ion-trap mass spectrometer through an automated elution-based interface. Gb3 molecular species, which were identified by HPTLC- Electrospray Mass Spectrometry (+)-MS and confirmed by MS/MS or HPTLC-Atmospheric Pressure Chemical Ionization Mass Spectrometry (+)-MS, are: five isoforms of saturated Gb3; seven isoforms of methylated Gb3; and seven species with two additional double bonds. Twelve of these species were previously reported as biomarkers of Fabry's lysosomal disorder using a Liquid Chromatography-MS-based method, and the other seven are structurally similar, closely related to them. Saturated Gb3 isoforms migrated on LiChrospher plate in one of the separated peaks corresponding to the migration zone of ceramide trihexosides standard. Instead, methylated and unsaturated Gb3 species co-migrated with sphingomyelin species. Ion intensity ESI-MS profiles show that saturated Gb3 species in Fabry's plasma were in higher concentration than in control sample. Before applying the Thin-Layer Chromatography (TLC)-MS interface on HPTLC separated peaks, its positioning precision was first studied using ceramide tri-hexosides as model compound. This provided information on Gb3 peak broadening and splitting during its migration.


Subject(s)
Chromatography, Thin Layer/methods , Densitometry , Fabry Disease/blood , Trihexosylceramides/blood , Biomarkers/blood , Fabry Disease/diagnosis , Humans , Methylation , Protein Isoforms/blood , Reference Standards , Spectrometry, Mass, Electrospray Ionization , Sphingolipids/blood , Tandem Mass Spectrometry , Trihexosylceramides/analysis , Trihexosylceramides/chemistry
5.
J Biol Chem ; 296: 100299, 2021.
Article in English | MEDLINE | ID: mdl-33460651

ABSTRACT

The human Gb3/CD77 synthase, encoded by the A4GALT gene, is an unusually promiscuous glycosyltransferase. It synthesizes the Galα1→4Gal linkage on two different glycosphingolipids (GSLs), producing globotriaosylceramide (Gb3, CD77, Pk) and the P1 antigen. Gb3 is the major receptor for Shiga toxins (Stxs) produced by enterohemorrhagic Escherichia coli. A single amino acid substitution (p.Q211E) ramps up the enzyme's promiscuity, rendering it able to attach Gal both to another Gal residue and to GalNAc, giving rise to NOR1 and NOR2 GSLs. Human Gb3/CD77 synthase was long believed to transfer Gal only to GSL acceptors, therefore its GSL products were, by default, considered the only human Stx receptors. Here, using soluble, recombinant human Gb3/CD77 synthase and p.Q211E mutein, we demonstrate that both enzymes can synthesize the P1 glycotope (terminal Galα1→4Galß1→4GlcNAc-R) on a complex type N-glycan and a synthetic N-glycoprotein (saposin D). Moreover, by transfection of CHO-Lec2 cells with vectors encoding human Gb3/CD77 synthase and its p.Q211E mutein, we demonstrate that both enzymes produce P1 glycotopes on N-glycoproteins, with the mutein exhibiting elevated activity. These P1-terminated N-glycoproteins are recognized by Stx1 but not Stx2 B subunits. Finally, cytotoxicity assays show that Stx1 can use P1 N-glycoproteins produced in CHO-Lec2 cells as functional receptors. We conclude that Stx1 can recognize and use P1 N-glycoproteins in addition to its canonical GSL receptors to enter and kill the cells, while Stx2 can use GSLs only. Collectively, these results may have important implications for our understanding of the Shiga toxin pathology.


Subject(s)
Galactosyltransferases/chemistry , Globosides/chemistry , Shiga Toxin 1/chemistry , Trihexosylceramides/chemistry , Acetylgalactosamine/chemistry , Acetylgalactosamine/metabolism , Acetylglucosamine/chemistry , Acetylglucosamine/metabolism , Animals , Binding Sites , CHO Cells , Carbohydrate Sequence , Cricetulus , Enterohemorrhagic Escherichia coli/chemistry , Enterohemorrhagic Escherichia coli/pathogenicity , Galactose/chemistry , Galactose/metabolism , Galactosyltransferases/genetics , Galactosyltransferases/metabolism , Gene Expression , Globosides/biosynthesis , Globosides/metabolism , Glucose/chemistry , Glucose/metabolism , Humans , Models, Molecular , Mutation , Protein Binding , Protein Conformation, alpha-Helical , Protein Conformation, beta-Strand , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Shiga Toxin 1/metabolism , Shiga Toxin 2/chemistry , Shiga Toxin 2/metabolism , Trihexosylceramides/biosynthesis
6.
Int J Med Microbiol ; 308(8): 1073-1084, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30224239

ABSTRACT

Shiga toxin (Stx)-mediated injury of the kidneys and the brain represent the major extraintestinal complications in humans upon infection by enterohemorrhagic Escherichia coli (EHEC). Damage of renal and cerebral endothelial cells is the key event in the pathogenesis of the life-threatening hemolytic uremic syndrome (HUS). Stxs are AB5 toxins and the B-pentamers of the two clinically important Stx subtypes Stx1a and Stx2a preferentially bind to the glycosphingolipid globotriaosylceramide (Gb3Cer, Galα4Galß4Glcß1Cer) and to less extent to globotetraosylceramide (Gb4Cer, GalNAcß3Galα4Galß4Glcß1), which are expected to reside in lipid rafts in the plasma membrane of the human endothelium. This review summarizes the current knowledge on the Stx glycosphingolipid receptors and their lipid membrane ensemble in primary human brain microvascular endothelial cells (pHBMECs) and primary human renal glomerular endothelial cells (pHRGECs). Increasing knowledge on the precise initial molecular mechanisms by which Stxs interact with cellular targets will help to develop specific therapeutics and/or preventive measures to combat EHEC-caused diseases.


Subject(s)
Enterohemorrhagic Escherichia coli/physiology , Escherichia coli Infections/metabolism , Globosides/metabolism , Shiga Toxin 1/metabolism , Shiga Toxin 2/metabolism , Trihexosylceramides/metabolism , Brain/cytology , Endothelial Cells/cytology , Enterohemorrhagic Escherichia coli/pathogenicity , Escherichia coli Infections/microbiology , Globosides/chemistry , Hemolytic-Uremic Syndrome/metabolism , Hemolytic-Uremic Syndrome/microbiology , Host-Pathogen Interactions/physiology , Humans , Kidney/cytology , Primary Cell Culture , Shiga Toxin 1/chemistry , Shiga Toxin 2/chemistry , Trihexosylceramides/chemistry
7.
Nanoscale ; 10(26): 12771-12778, 2018 Jul 09.
Article in English | MEDLINE | ID: mdl-29946584

ABSTRACT

The human opportunistic pathogen Pseudomonas aeruginosa (PA) is responsible for chronic infections of the respiratory epithelium in cystic fibrosis patients. PA takes advantage of an arsenal of virulence factors to infect and colonize human lungs. Among them, the lectin LecA favours epithelium invasion by interacting with host cell globotriaosylceramide (Gb3). A new therapeutic approach is based on the development of synthetic multivalent molecules (glycoclusters) targeting LecA with a higher affinity than its natural ligand. Atomic force microscopy-single cell force spectroscopy has been used to study the effect of glycoclusters on the bacteria-cell interaction. Glycoclusters have been shown to affect the detachment work and detachment force of the bacteria-cell interaction. The specificity and the efficiency of the glycocluster in targeting the lectin and destabilizing the PA-epithelial cell adhesion are demonstrated and discussed.


Subject(s)
Adhesins, Bacterial/chemistry , Bacterial Adhesion , Epithelial Cells/microbiology , Pseudomonas aeruginosa/cytology , Trihexosylceramides/chemistry , Cell Line , Humans , Microscopy, Atomic Force , Single-Cell Analysis , Spectrum Analysis
8.
Toxins (Basel) ; 9(11)2017 10 25.
Article in English | MEDLINE | ID: mdl-29068380

ABSTRACT

Shiga toxins (Stxs) released by enterohemorrhagic Escherichia coli (EHEC) into the human colon are the causative agents for fatal outcome of EHEC infections. Colon epithelial Caco-2 and HCT-8 cells are widely used for investigating Stx-mediated intestinal cytotoxicity. Only limited data are available regarding precise structures of their Stx receptor glycosphingolipids (GSLs) globotriaosylceramide (Gb3Cer) and globotetraosylceramide (Gb4Cer), and lipid raft association. In this study we identified Gb3Cer and Gb4Cer lipoforms of serum-free cultivated Caco-2 and HCT-8 cells, chiefly harboring ceramide moieties composed of sphingosine (d18:1) and C16:0, C22:0 or C24:0/C24:1 fatty acid. The most significant difference between the two cell lines was the prevalence of Gb3Cer with C16 fatty acid in HCT-8 and Gb4Cer with C22-C24 fatty acids in Caco-2 cells. Lipid compositional analysis of detergent-resistant membranes (DRMs), which were used as lipid raft-equivalents, indicated slightly higher relative content of Stx receptor Gb3Cer in DRMs of HCT-8 cells when compared to Caco-2 cells. Cytotoxicity assays revealed substantial sensitivity towards Stx2a for both cell lines, evidencing little higher susceptibility of Caco-2 cells versus HCT-8 cells. Collectively, Caco-2 and HCT-8 cells express a plethora of different receptor lipoforms and are susceptible towards Stx2a exhibiting somewhat lower sensitivity when compared to Vero cells.


Subject(s)
Epithelial Cells/chemistry , Trihexosylceramides/chemistry , Cell Line , Cell Survival/drug effects , Colon/cytology , Epithelial Cells/drug effects , Humans , Shiga Toxin 2/toxicity
9.
ACS Nano ; 11(1): 314-324, 2017 01 24.
Article in English | MEDLINE | ID: mdl-27943675

ABSTRACT

The bacterial Shiga toxin interacts with its cellular receptor, the glycosphingolipid globotriaosylceramide (Gb3 or CD77), as a first step to entering target cells. Previous studies have shown that toxin molecules cluster on the plasma membrane, despite the apparent lack of direct interactions between them. The precise mechanism by which this clustering occurs remains poorly defined. Here, we used vesicle and cell systems and computer simulations to show that line tension due to curvature, height, or compositional mismatch, and lipid or solvent depletion cannot drive the clustering of Shiga toxin molecules. By contrast, in coarse-grained computer simulations, a correlation was found between clustering and toxin nanoparticle-driven suppression of membrane fluctuations, and experimentally we observed that clustering required the toxin molecules to be tightly bound to the membrane surface. The most likely interpretation of these findings is that a membrane fluctuation-induced force generates an effective attraction between toxin molecules. Such force would be of similar strength to the electrostatic force at separations around 1 nm, remain strong at distances up to the size of toxin molecules (several nanometers), and persist even beyond. This force is predicted to operate between manufactured nanoparticles providing they are sufficiently rigid and tightly bound to the plasma membrane, thereby suggesting a route for the targeting of nanoparticles to cells for biomedical applications.


Subject(s)
Cell Membrane/chemistry , Nanoparticles/chemistry , Shiga Toxin/chemistry , Trihexosylceramides/chemistry , Humans , Static Electricity
10.
Glycobiology ; 27(1): 99-109, 2017 01.
Article in English | MEDLINE | ID: mdl-27558838

ABSTRACT

Shiga toxin (Stx)-mediated injury to microvascular endothelial cells in the brain significantly contributes to the pathogenesis of the hemolytic-uremic syndrome caused by enterohemorrhagic Escherichia coli (EHEC). Stxs are AB5 toxins and the B-pentamers of the two major Stx subtypes Stx1a and Stx2a preferentially bind to the glycosphingolipid (GSL) globotriaosylceramide (Gb3Cer) expressed by human endothelial cells. Here we report on comprehensive structural analysis of the different lipoforms of Gb3Cer (Galα4Galß4Glcß1Cer) and globotetraosylceramide (Gb4Cer, GalNAcß3Galα4Galß4Glcß1Cer, the less effective Stx receptor) of primary human brain microvascular endothelial cells and their association with lipid rafts. Detergent-resistant membranes (DRMs), obtained by sucrose density gradient ultracentrifugation, were used as lipid raft-analogous microdomains of the liquid-ordered phase and nonDRM fractions were employed as equivalents for the liquid-disordered phase of cell membranes. Structures of the prevalent lipoforms of Gb3Cer and Gb4Cer were those with Cer (d18:1, C16:0), Cer (d18:1, C22:0) and Cer (d18:1, C24:1/C24:0) determined by electrospray ionization mass spectrometry that was combined with thin-layer chromatography immunodetection using anti-Gb3Cer and anti-Gb4Cer antibodies as well as Stx1a and Stx2a subtypes. Association of Stx receptor GSLs was determined by co-localization with lipid raft-specific membrane protein flotillin-2 and canonical lipid raft marker sphingomyelin with Cer (d18:1, C16:0) and Cer (d18:1, C24:1/C24:0) in the liquid-ordered phase, whereas lyso-phosphatidylcholine was detectable exclusively in the liquid-disordered phase. Defining the precise microdomain structures of primary endothelial cells may help to unravel the initial mechanisms by which Stxs interact with their target cells and will help to develop novel preventive and therapeutic measures for EHEC-mediated diseases.


Subject(s)
Globosides/chemistry , Receptors, Cell Surface/chemistry , Shiga Toxin 1/chemistry , Shiga Toxin 2/chemistry , Trihexosylceramides/chemistry , Antibodies/chemistry , Blood-Brain Barrier/chemistry , Blood-Brain Barrier/metabolism , Chromatography, Thin Layer , Endothelial Cells/chemistry , Escherichia coli/pathogenicity , Globosides/genetics , Glycosphingolipids/chemistry , Glycosphingolipids/genetics , Humans , Membrane Microdomains/chemistry , Membrane Microdomains/genetics , Receptors, Cell Surface/genetics , Shiga Toxin 1/genetics , Shiga Toxin 2/genetics , Trihexosylceramides/genetics
11.
Mol Genet Metab ; 120(1-2): 116-120, 2017.
Article in English | MEDLINE | ID: mdl-27756537

ABSTRACT

In Fabry disease, large amounts of globotriaosylceramide (Gb3) and related glycosphingolipids accumulate in organs due to a deficiency of α-galactosidase A (GLA) activity. Enzyme replacement therapy (ERT) with recombinant GLA is now available, and it has been reported that ERT is beneficial for patients with Fabry disease, especially those who start treatment at an early stage of the disease. However, it seems that the efficacy of ERT differs with each organ, and Gb3 accumulated in the kidneys shows resistance to ERT when it is started at a late stage. In this study, we examined the differences in cleavage of Gb3 isoforms, and lyso-Gb3 and its analogues in the kidneys, liver, and heart in young Fabry mice subjected to ERT. The results revealed that recurrent administration of recombinant GLA had prominent effects in terms of degradation of Gb3 and its derivatives accumulated in the organs. However, particular Gb3 isoforms, i.e., Gb3 (C20:0) and Gb3 (C24OH), accumulated in the kidneys largely escaped from degradation. Such Gb3 isoforms may gradually accumulate in the kidneys from a young age, which results in a reduction in the efficacy of ERT for Fabry disease.


Subject(s)
Fabry Disease/drug therapy , Isoenzymes/therapeutic use , Kidney/metabolism , Trihexosylceramides/chemistry , alpha-Galactosidase/therapeutic use , Animals , Disease Models, Animal , Drug Resistance , Enzyme Replacement Therapy , Fabry Disease/metabolism , Humans , Mice
12.
Curr Protoc Hum Genet ; 91: 17.24.1-17.24.11, 2016 10 11.
Article in English | MEDLINE | ID: mdl-27727434

ABSTRACT

Fabry disease is a multisystemic, X-linked lysosomal storage disorder caused by mutations in the GLA gene, leading to α-galactosidase A deficiency and resulting in the accumulation of glycosphingolipids in different tissues and biological fluids. Glycosphingolipid biomarkers, such as globotriaosylceramide (Gb3 ) isoforms, globotriaosylsphingosine (lyso-Gb3 ) and related analogs, and galabiosylceramide (Ga2 ) isoforms and analogs, are found to be abnormally increased in urine and in plasma of Fabry patients and have the potential to be used as specific biomarkers of the disease. This unit presents a protocol for the relative quantification of fifteen urinary isoforms of Gb3 analyzed simultaneously with creatinine by ultra-performance liquid chromatography (UPLC) coupled to tandem mass spectrometry (MS/MS). In order to purify urine samples, a liquid-liquid extraction is performed and samples are analyzed by MS/MS in positive electrospray ionization mode. These biomarkers are useful for screening, diagnosis, and long-term monitoring of Fabry disease patients. We have shown that the methylated Gb3 isoforms are particularly useful for screening Fabry patients who present with late-onset cardiac variant mutations. © 2016 by John Wiley & Sons, Inc.


Subject(s)
Fabry Disease/diagnosis , Tandem Mass Spectrometry , Trihexosylceramides/chemistry , Trihexosylceramides/urine , Creatinine/urine , Fabry Disease/urine , Female , Glycolipids/chemistry , Glycolipids/urine , Humans , Liquid-Liquid Extraction , Male , Methylation , Protein Isoforms/chemistry , Protein Isoforms/urine , Sphingolipids/chemistry , Sphingolipids/urine
13.
Soft Matter ; 12(23): 5164-71, 2016 Jun 21.
Article in English | MEDLINE | ID: mdl-27070906

ABSTRACT

The bacterial Shiga toxin is composed of an enzymatically active A-subunit, and a receptor-binding homopentameric B-subunit (STxB) that mediates intracellular toxin trafficking. Upon STxB-mediated binding to the glycolipid globotriaosylceramide (Gb3) at the plasma membrane of target cells, Shiga toxin is internalized by clathrin-dependent and independent endocytosis. The formation of tubular membrane invaginations is an essential step in the clathrin-independent STxB uptake process. However, the mechanism by which STxB induces these invaginations has remained unclear. Using a combination of all-atom molecular dynamics and Monte Carlo simulations we show that the molecular architecture of STxB enables the following sequence of events: the Gb3 binding sites on STxB are arranged such that tight avidity-based binding results in a small increment of local curvature. Membrane-mediated clustering of several toxin molecules then creates a tubular membrane invagination that drives toxin entry into the cell. This mechanism requires: (1) a precise molecular architecture of the STxB binding sites; (2) a fluid bilayer in order for the tubular invagination to form. Although, STxB binding to the membrane requires specific interactions with Gb3 lipids, our study points to a generic molecular design principle for clathrin-independent endocytosis of nanoparticles.


Subject(s)
Endocytosis , Shiga Toxin/chemistry , Trihexosylceramides/chemistry , Binding Sites , Cell Membrane , Molecular Structure , Protein Transport
14.
FEBS Lett ; 590(9): 1384-92, 2016 05.
Article in English | MEDLINE | ID: mdl-27086582

ABSTRACT

The recently identified Streptococcus suis adhesin factor H-binding protein (Fhb) targets the host cellular receptor glycolipid GbO3 through its N terminus. However, it is unclear how Fhb interacts with its receptor. Here, we determined the complex structure of factor H-binding protein receptor-binding domain (Fhb RBD) with Gb2, an analog of its receptor, revealing that Gb2 binds in a pocket of the ß sandwich core domain. We identified the key residues for Fhb RBD receptor binding using mutagenesis and isothermal titration calorimetry. Mutagenesis analyses indicated that Fhb binds to Gb2 mainly through hydrogen and hydrophobic interactions. Our findings provided structural insights into the Fhb-mediated host-pathogen interactions of S. suis.


Subject(s)
Adhesins, Bacterial/chemistry , Streptococcus suis/chemistry , Trihexosylceramides/metabolism , Adhesins, Bacterial/genetics , Adhesins, Bacterial/metabolism , Binding Sites , Humans , Point Mutation , Protein Binding , Streptococcus suis/pathogenicity , Trihexosylceramides/chemistry
15.
Clin Chim Acta ; 452: 191-8, 2016 Jan 15.
Article in English | MEDLINE | ID: mdl-26593248

ABSTRACT

BACKGROUND: Fabry disease is a lysosomal storage disorder leading to the accumulation of glycosphingolipids in biological fluids and tissues. Globotriaosylceramide (Gb3) and globotriaosylsphingosine (lyso-Gb3) are currently used for Fabry screening and diagnosis. However, these biomarkers are not always increased in Fabry patients with residual enzyme activity. We recently identified 7 urinary methylated Gb3-related isoforms. The aims of this study were (1) to develop and validate a novel LC-MS/MS method for the relative quantification of methylated and non-methylated Gb3 isoforms normalized to creatinine, (2) to evaluate these biomarkers in Fabry patients and healthy controls, and (3) to assess correlations between biomarker urinary excretion with age, gender, treatment and genotype of patients. METHODS: Urine samples from 150 Fabry patients and 95 healthy controls were analyzed. Samples were purified and injected in the tandem mass spectrometer working in positive electrospray ionization. Relative quantification was performed for 15 methylated and non-methylated Gb3 isoforms. RESULTS: Significant correlations (p<0.001) were established between Gb3 isoform concentrations, gender and treatment. Five patients with the late-onset cardiac mutation p.N215S showed abnormal concentrations of methylated Gb3 isoforms compared to their non-methylated homologues. CONCLUSIONS: Methylated Gb3 isoforms might be helpful urinary biomarkers for Fabry patients with late-onset cardiac variant mutations.


Subject(s)
Fabry Disease/urine , Glycolipids/urine , Sphingolipids/urine , Trihexosylceramides/urine , Adolescent , Adult , Aged , Calibration , Child , Child, Preschool , Fabry Disease/metabolism , Female , Glycolipids/chemistry , Glycolipids/metabolism , Humans , Infant , Male , Methylation , Middle Aged , Molecular Structure , Protein Isoforms/chemistry , Protein Isoforms/metabolism , Protein Isoforms/urine , Sphingolipids/chemistry , Sphingolipids/metabolism , Tandem Mass Spectrometry , Trihexosylceramides/chemistry , Trihexosylceramides/metabolism , Young Adult
16.
PLoS One ; 10(12): e0144958, 2015.
Article in English | MEDLINE | ID: mdl-26661087

ABSTRACT

Fabry disease is caused by deficient activity of α-galactosidase A (GLA) and characterized by systemic accumulation of glycosphingolipids, substrates of the enzyme. To gain insight into the pathogenesis of Fabry disease based on accumulated substrates, we examined the tissue and plasma distributions of globotriaosylceramide (Gb3) isoforms, and globotriaosylsphingosine (lyso-Gb3) and its analogues in a GLA knockout mouse, a model of Fabry disease, by means of liquid chromatography-mass spectrometry and nano-liquid chromatography-tandem mass spectrometry, respectively. The results revealed that the contents of these substrates in the liver, kidneys, heart, and plasma of GLA knockout mice were apparently higher than in those of wild-type ones, and organ specificity in the accumulation of Gb3 isoforms was found. Especially in the kidneys, accumulation of a large amount of Gb3 isoforms including hydroxylated residues was found. In the GLA knockout mice, the proportion of hydrophobic Gb3 isoforms was apparently higher than that in the wild-type mice. On the other hand, hydrophilic residues were abundant in plasma. Unlike that of Gb3, the concentration of lyso-Gb3 was high in the liver, and the lyso-Gb3/Gb3 ratio in plasma was significantly higher than those in the organs. The concentration of lyso-Gb3 was apparently higher than those of its analogues in the organs and plasma from both the GLA knockout and wild-type mice. This information will be useful for elucidating the basis of Fabry disease.


Subject(s)
Fabry Disease/physiopathology , Glycolipids/metabolism , Sphingolipids/metabolism , Trihexosylceramides/metabolism , alpha-Galactosidase/genetics , Animals , Chromatography, High Pressure Liquid , Disease Models, Animal , Female , Glycolipids/analysis , Glycolipids/chemistry , Isomerism , Kidney/metabolism , Liver/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Myocardium/metabolism , Sphingolipids/analysis , Sphingolipids/chemistry , Tandem Mass Spectrometry , Trihexosylceramides/analysis , Trihexosylceramides/chemistry , alpha-Galactosidase/metabolism
17.
Clin Chim Acta ; 447: 96-104, 2015 Jul 20.
Article in English | MEDLINE | ID: mdl-26070511

ABSTRACT

Recent data have shown that lyso-Gb3, the deacylated derivative of globotriaosylceramide (Gb3), is possibly involved in the pathogenesis of Fabry disease (FD) and might be a clinically useful biomarker of its metabolic load. To test this hypothesis, we assayed Gb3 and lyso-Gb3 and related analogs in plasma and/or urine samples of 12 clinically well-characterized subjects carrying several different GLA variant alleles associated with a wide range of residual α-galactosidase A activities. Urinary Gb3 was measured by HPLC-MS/MS; plasma and urinary lyso-Gb3 and related analogs were measured by UPLC-MS/MS. Individual profiles of Gb3 and lyso-Gb3 and related analogs closely correlated with the phenotypic data for each subject, discerning the classical FD patient from the two patients carrying cardiac variants as well as those from all the others without FD. The lyso-Gb3 analog at m/z 836 was found at increased levels only in patients manifesting clinically severe heart disease, irrespective of the pathogenicity of the GLA variant they carried. This finding suggests that this lyso-Gb3 analog might be an earlier biomarker of progressive heart disease, non-specific of the FD cardiomyopathy. The possibility that urinary Gb3 is a specific marker of kidney involvement in FD deserves further study.


Subject(s)
Glycolipids/blood , Glycolipids/urine , Mutation , Sphingolipids/blood , Sphingolipids/urine , Trihexosylceramides/blood , Trihexosylceramides/urine , alpha-Galactosidase/genetics , Adult , Aged , Alleles , Fabry Disease/blood , Fabry Disease/enzymology , Fabry Disease/genetics , Fabry Disease/urine , Glycolipids/chemistry , Humans , Male , Middle Aged , Models, Molecular , Protein Conformation , Sphingolipids/chemistry , Trihexosylceramides/chemistry , Young Adult , alpha-Galactosidase/chemistry
18.
Biophys J ; 108(12): 2775-8, 2015 Jun 16.
Article in English | MEDLINE | ID: mdl-26083916

ABSTRACT

Shiga toxin subunit B (STxB) binding to its cellular receptor Gb3 leads to the formation of protein-lipid clusters and bending of the membrane. A newly developed synthetic route allowed synthesizing the biologically most relevant Gb3-C24:1 2OH species with both, the natural (Gb3-R) as well as the unnatural (Gb3-S) configuration of the 2OH group. The derivatives bind STxB with identical nanomolar affinity, while the propensity to induce membrane tubules in giant unilamellar vesicles is more pronounced for Gb3-S. Fluorescence and atomic force microscopy images of phase-separated supported membranes revealed differences in the lateral organization of the protein on the membrane. Gb3-R favorably induces large and tightly packed protein clusters, while a lower protein density is found on Gb3-S doped membranes.


Subject(s)
Cell Membrane/ultrastructure , Fatty Acids/metabolism , Hydroxy Acids/metabolism , Shiga Toxin 2/metabolism , Trihexosylceramides/metabolism , Cell Membrane/metabolism , Fatty Acids/chemistry , Hydroxy Acids/chemistry , Protein Binding , Shiga Toxin 2/chemistry , Trihexosylceramides/chemistry , Unilamellar Liposomes/chemistry , Unilamellar Liposomes/metabolism
19.
Soft Matter ; 11(7): 1352-61, 2015 Feb 04.
Article in English | MEDLINE | ID: mdl-25575293

ABSTRACT

Globotriaosylceramide (Gb3) is a glycosphingolipid present in the plasma membrane that is the natural receptor of the bacterial Shiga toxin. The unsaturation level of Gb3 acyl chains has a drastic impact on lipid bilayer properties and phase behaviour, and on many Gb3-related cellular processes. For example: the Shiga toxin B subunit forms tubular invaginations in the presence of Gb3 with an unsaturated acyl chain (U-Gb3), while in the presence of Gb3 with a saturated acyl chain (S-Gb3) such invagination does not occur. We have used all-atom molecular dynamics simulations to investigate the effects of the Gb3 concentration and its acyl chain saturation on the phase behaviour of a mixed bilayer of dioleoylphosphatidylcholine and Gb3. The simulation results show that: (1) the Gb3 acyl chains (longer tails) from one leaflet interdigitate into the opposing leaflet and lead to significant bilayer rigidification and immobilisation of the lipid tails. S-Gb3 can form a highly ordered, relatively immobile phase which is resistant to bending while these changes for U-Gb3 are not significant. (2) At low concentrations of Gb3, U-Gb3 and S-Gb3 have a similar impact on the bilayer reminiscent of the effect of sphingomyelin lipids and (3) At higher Gb3 concentrations, U-Gb3 mixes better with dioleoylphosphatidylcholine than S-Gb3. Our simulations also provide the first molecular level structural model of Gb3 in membranes.


Subject(s)
Lipid Bilayers/chemistry , Trihexosylceramides/chemistry , Molecular Dynamics Simulation , Phosphatidylcholines/chemistry
20.
Soft Matter ; 11(1): 186-92, 2015 Jan 07.
Article in English | MEDLINE | ID: mdl-25376469

ABSTRACT

Lateral variation of the in-plane orientation of lipids in a bilayer is referred to as texture. The influence of the protein Shiga toxin on orientational membrane texture was studied in phosphatidylcholine lipid bilayers using polarization two-photon fluorescence microscopy and atomic force microscopy. A content of 1% of glycosphingolipid globotriaosylceramide (Gb3) receptor lipids in a bilayer was used to bind the Shiga toxin B-subunit to the surface of gel domains. Binding of the Shiga toxin B-subunit to lipids led to the modulation of orientational membrane texture in gel domains and induced membrane reordering. When Shiga toxin was added above the lipid chain melting temperature, the toxin interaction with the membrane induced rearrangement and clustering of Gb3 lipids that resulted in the long range order and alignment of lipids in gel domains. The toxin induced redistribution of Gb3 lipids inside gel domains is governed by the temperature at which Shiga toxin was added to the membrane: above or below the phase transition. The temperature is thus one of the critical factors controlling lipid organization and texture in the presence of Shiga toxin. Lipid chain ordering imposed by Shiga toxin binding can be another factor driving the reconstruction of lipid organization and crystallization of lipids inside gel domains.


Subject(s)
Dysentery, Bacillary/microbiology , Lipid Bilayers/metabolism , Phospholipids/metabolism , Shiga Toxin/metabolism , Shigella dysenteriae/metabolism , Trihexosylceramides/metabolism , Humans , Lipid Bilayers/chemistry , Phase Transition , Phospholipids/chemistry , Trihexosylceramides/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...